Bruker and 10x Genomics have agreed to settle a patent dispute relating to products originally developed by Nanostring, a company Bruker acquired in 2024. Under the settlement, whose financial ...

As you might know, 10x Genomics, Inc. (NASDAQ:TXG) just kicked off its latest quarterly results with some very strong numbers. The results overall were pretty good, with revenues of US$155m ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-first-quarter-2025-financial-results-302450468.html SOURCE ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s ...

As you might know, 10x Genomics, Inc. (NASDAQ:TXG) just kicked off its latest quarterly results with some very strong numbers. The results overall were pretty good, with revenues of US$155m exceeding ...